Hallie Levine April 04, 2023 Lisa McCorkell had a mild bout of COVID-19 in March 2020. Young and healthy, she assumed that she would bounce back quickly. But when her fatigue, shortness of breath, and brain fog persisted, she realized that she most likely had long COVID. “Back then, we as patients basically coined the term,” she...
Month: <span>April 2023</span>
Post
Study finds doxycycline reduces sexually transmitted infections by two-thirds
by NIH/National Institute of Allergy and Infectious Diseases Scanned electron micrograph image of Neisseria gonorrhoeae bacteria, which can cause gonorrhea. Credit: NIAID The oral antibiotic doxycycline prevented the acquisition of sexually transmitted infections (STIs) when tested among men who have sex with men (MSM) and transgender women who took the medication within 72 hours of...
Post
Common brain cyst and neurodevelopmental disorders share genetic drivers
by Jennifer Chen, Yale University Credit: Unsplash/CC0 Public Domain Often an incidental finding on brain scans looking for trauma or other neurological conditions, arachnoid cysts (ACs) are small, fluid-filled sacs within the arachnoid membrane, one of three layers protecting the brain and spinal cord. They often don’t cause noticeable symptoms; however, when they do, patients...
Post
CRC Blood Tests: A Future Without Screening Colonoscopies?
Kerry Dooley Young April 05, 2023 US regulators may soon clear blood-based biomarker tests for colorectal cancer (CRC), expanding potential options for patients seeking more convenient forms of screening. Most recently, Guardant Health, Inc, announced the completion of its US premarket approval application for its Shield blood test to screen for CRC. Approval by the US Food and Drug...
Post
New study could change assumptions about helmet safety
by New York Institute of Technology The model comprises different parts such as the skull, cerebrum, cerebellum, pituitary gland, and brain stem along with subarachnoid space and other cavities filled with fluid particles. Additionally, displayed is half of the skull to give better insight into its structure. The helmet included in the model has two...
Post
Spinal cord injury induces an immune deficiency in patients, study finds
by The Ohio State University B Cells Extravasate, Convert Into Plasma Cells, and Synthesize Antibodies in Subacute Spinal Cord Injury (SCI) Lesions After Human SCI. B cells leave the vessel lumen (extravasate) and populate the perivascular space (2 weeks after SCI). These findings are corroborated by the detection of 2 different B cell antigens, CD20...
Post
Long-COVID fatigue reduced by over 50% in active individuals compared to sedentary
By Dr. Priyom Bose, Ph.D. Apr 5 2023 Reviewed by Lily Ramsey, LLM The ongoing coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus, has claimed more than 6.88 million lives worldwide. Many studies have reported the manifestation of long-COVID, which has been described as the persistence of COVID-19 symptoms for at...
Post
Does Vitamin D Deficiency Cause Obesity or Vice Versa?
Caroline Apovian, MD December 27, 2022 Caroline Apovian, MD A recent study found that people with obesity have lower blood levels of vitamin D than people of healthy weight. This association of obesity with low vitamin D levels has led to much speculation on whether low vitamin D levels cause obesity or whether obesity causes low vitamin D levels. The interest in this...
Post
The billionaire’s online pharmacy will offer one of the most expensive treatments for type 2 diabetes at half the price
LUC OLINGA 13 HOURS AGO Mark Cuban is on a mission to disrupt the drug industry. The tech billionaire co-founded online pharmacy CostPlus Drug Company, the only company that bears his name, in January 2022. While the task is daunting and many other big names in the corporate world have tried to slash drug prices...
Post
New Recommendations for Weight Loss Drugs
By Patrick Wingrove March 31, 2023 (Reuters) – Novo Nordisk’s Wegovy won U.S. approval in June 2021 with a label that says it can be used for chronic weight management in patients with a body mass index (BMI) of 27 or more who have at least one weight-related ailment, or in any patient with a BMI of...